12,661,404 5,164,685
Leases payable - long term - 11,645
Accrued severance payable, long term 313,589 619,643
12,974,993 5,795,973
Commitments and Contingencies
Stockholders' equity
Common stock $.001 par value;
40,000,000 shares authorized;
17,013,056 and 16,858,539 shares
issued and 16,991,056 and
16,836,539 outstanding,
respectively 17,013 16,859
Paid-in capital 54,885,049 53,433,095
Accumulated deficit (51,423,068) (38,354,696)
Accumulated other comprehensive loss
Unrealized loss on securities
available for sale (14,094) (4,768)
3,464,900 15,090,490
Less treasury stock at cost, 22,000
common shares (75,625) (75,625)
Total stockholders' equity 3,389,275 15,014,865
$ 16,364,268 $ 20,810,838
QMED, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)
For the For the For the For the
Three Three Nine Nine
Months Months Months Months
Ended Ended Ended Ended
August 31, August 31, August 31, August 31,
2007 2006 2007 2006
Revenue $10,781,247
'/>"/>
| SOURCE QMed, Inc. Copyright©2007 PR Newswire. All rights reserved |